The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Cooley (UK) LLP

Living Wage
Work 020 7583 4055
Fax 020 7785 9355

Nicola Maguire

Work +44 (0) 20 7583 4055
Cooley LLP

Work Department

Emerging Companies
Mergers & Acquisitions
Public Companies
Life Sciences Corporate Partnering & Licensing
Intellectual Property
Health Care
Life Sciences


Nicola Maguire is a partner in Cooley's Life Sciences practice and is resident in the London office. She has developed a practice specialising in advising life sciences companies and other clients whose businesses have a significant reliance on intellectual property.

Many of the transactions on which Nicola works have a significant international element, with parties in the U.S. or Europe. Nicola's experience includes advising on the acquisition for Swedish listed company Meda AB of an Italian specialty pharma company, Rottapharm, for the Danish, listed company Ambu A/S on its acquisition of King Systems, a US subsidiary of UK listed company, Consort Medical, on the creation of an Indian joint venture between the Wellcome Trust and Merck and on the creation of a joint venture between Swedish company, Karolinska Development and UK based Rosetta Capital. Transactions such as this illustrate the cross-border nature of Nicola's practice. She has particular expertise advising clients at all stages of development, from early stage startups to listed companies, and on mergers and acquisitions, joint ventures and equity fundings. 

Nicola's practice also includes advising on general commercial matters such as materials transfer agreements, intellectual property licences, research and collaboration agreements and distribution and manufacturing agreements. Recent transactions include acting for the Wellcome Trust on its collaboration relating to dengue fever with the University of Leuven and Janssen and for King's College London on a licence and development agreement with UCB. 



Nicola was previously a partner at Reed Smith from 2005 – 2015 and Bird & Bird from 2001 to 2005. Previously, she worked at GE Lighting and Cable & Wireless Communications.




  • University of Bristol
    PGD, 2004
  • College of Law, Guildford
    LPC, 1987
  • Manchester University
    LLB, 1986

London: TMT (technology, media and telecoms)

Intellectual property

Within: Intellectual property

The 'excellent' intellectual property team at Cooley (UK) LLP¬†attracts praise for being 'easy to work with, proactive and for offering practical advice'. The group is particularly known for trade mark work;¬†clients include Twitter, for which it handles on all aspect of its European trade mark matters, from filing to enforcement. The group also act for¬†VF¬†Corporation and Yum! Brands on trade mark issues.¬†The 'highly responsive' Nicholas Bolter¬†¬†is recommended as being 'business-friendly advice and great results' particularly in relation to trade mark and design rights. Other key names to note include Nicola Maguire¬†and John Wilkinson,¬†who focus on the life sciences sector.¬†Maguire led a team advising Enterome on its¬†‚ā¨40m joint venture with Nestl√© Health Science, which included joint venture agreement, cross licences and an agreement for the provision of services.

[back to top]

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

The 'excellent' Cooley (UK) LLP handles IP and transactional matters in this sector. The 'outstanding' John Wilkinson jointly heads the practice and has 'an encyclopaedic knowledge of life sciences and legal detail'. He has expertise in the areas of IP, regulatory, competition and transactions, and recently advised Addex on its collaboration with Individior with the aim of developing a product to treat addiction. Fellow practice head Nicola Maguire is an expert in non-contentious IP issues and assisted PhoreMost with licensing technology from the University of Turin. Patent attorney Colm Murphy defended Illumina against challenges to its patents after it acquired Solexa. Corporate transactions specialist Stephen Rosen advised Orchard Therapeutics on its $110m Series B financing from Baillie Gifford and ORI Capital. Corporate specialist Ed  Lukins is also recommended.

[back to top]

Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to